These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

523 related items for PubMed ID: 12655535

  • 1. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H, Gómez S, Ruvinsky S, Zubizarreta P, Latella A, Fraquelli L, Iturres AS, Casimir L, Debbag R.
    Cancer; 2003 Apr 01; 97(7):1775-80. PubMed ID: 12655535
    [Abstract] [Full Text] [Related]

  • 2. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H, Rodriguez-Brieshcke T, Zubizarreta P, Latella A, Firpo V, Casimir L, Armada A, Fernández C, Cáceres E, Debbag R.
    Cancer; 2001 Apr 15; 91(8):1563-7. PubMed ID: 11301406
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia.
    Gupta A, Swaroop C, Agarwala S, Pandey RM, Bakhshi S.
    J Pediatr Hematol Oncol; 2009 Sep 15; 31(9):635-41. PubMed ID: 19684522
    [Abstract] [Full Text] [Related]

  • 4. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 15; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 5. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M, Hornedo J, Lumbreras C, Trigo JM, Colomer R, Perea S, Gómez C, Ruiz A, García-Carbonero R, Cortés-Funes H.
    Cancer; 1999 Jan 01; 85(1):213-9. PubMed ID: 9921995
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR, Coughlin J, Hawkins D, Friedman DL, Burns JL, Pendergrass T.
    Med Pediatr Oncol; 2003 Feb 01; 40(2):93-8. PubMed ID: 12461792
    [Abstract] [Full Text] [Related]

  • 8. A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
    Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.
    N Engl J Med; 1999 Jul 29; 341(5):305-11. PubMed ID: 10423464
    [Abstract] [Full Text] [Related]

  • 9. Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
    Aquino VM, Herrera L, Sandler ES, Buchanan GR.
    Cancer; 2000 Apr 01; 88(7):1710-4. PubMed ID: 10738231
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML.
    J Microbiol Immunol Infect; 2009 Apr 01; 42(2):141-7. PubMed ID: 19597646
    [Abstract] [Full Text] [Related]

  • 14. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
    Metallidis S, Kollaras P, Giannakakis T, Seitanidis B, Kordosis T, Nikolaidis J, Hatzitolios A, Nikolaidis P.
    Eur J Intern Med; 2008 Dec 01; 19(8):619-24. PubMed ID: 19046729
    [Abstract] [Full Text] [Related]

  • 15. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR, Sarkis CM, De Martino MG, Zubizarreta PA, Casimir L, Fernandez C, Armada AA, Rodriguez-Brieshcke MT, Debbag R.
    Cancer; 2000 Jun 15; 88(12):2848-52. PubMed ID: 10870071
    [Abstract] [Full Text] [Related]

  • 16. Inpatient versus outpatient management of low-risk pediatric febrile neutropenia: measuring parents' and healthcare professionals' preferences.
    Sung L, Feldman BM, Schwamborn G, Paczesny D, Cochrane A, Greenberg ML, Maloney AM, Hendershot EI, Naqvi A, Barrera M, Llewellyn-Thomas HA.
    J Clin Oncol; 2004 Oct 01; 22(19):3922-9. PubMed ID: 15459214
    [Abstract] [Full Text] [Related]

  • 17. Outpatient treatment of low-risk neutropenic fever in cancer patients using oral moxifloxacin.
    Chamilos G, Bamias A, Efstathiou E, Zorzou PM, Kastritis E, Kostis E, Papadimitriou C, Dimopoulos MA.
    Cancer; 2005 Jun 15; 103(12):2629-35. PubMed ID: 15856427
    [Abstract] [Full Text] [Related]

  • 18. Ambulatory treatment with ceftriaxone in febrile neutropenic children.
    Kaplinsky C, Drucker M, Goshen J, Tamary H, Cohen IJ, Zaizov R.
    Isr J Med Sci; 1994 Aug 15; 30(8):649-51. PubMed ID: 8045751
    [Abstract] [Full Text] [Related]

  • 19. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S.
    Minerva Pediatr; 2003 Oct 15; 55(5):395-406. PubMed ID: 14608263
    [Abstract] [Full Text] [Related]

  • 20. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
    Wilimas JA, Flynn PM, Harris S, Day SW, Smith R, Chesney PJ, Rodman JH, Eguiguren JM, Fairclough DL, Wang WC.
    N Engl J Med; 1993 Aug 12; 329(7):472-6. PubMed ID: 8332152
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.